Skip to main content
. Author manuscript; available in PMC: 2011 Mar 4.
Published in final edited form as: Brain Res. 2009 Nov 26;1317:124–136. doi: 10.1016/j.brainres.2009.11.034

Table 2.

Clinical Characteristics of Participants with LCVA

Participant Months
Post CVA
Brodmann’s areas lesioned* Total voxels
lesioned
Patient TO 105 21,22,37,39,40,41,42,43,44 39,674
OM 74 1,2,3,7,19,21,22,37,39,40,41,42,43 32,238
MA 69 6,44,47 2,288
AG 129 6,9,45,46 72,991
GH 75 7,22,39,40,41,42 57,196
LL 101 1,2,3,4,9,22,32,34,38,39,40,41,42,43,45,47 27,492
  Avg. (sd) 92 (24) 38,646 (24,544)
*

≥10% damage to listed regions